Skip to the content
Caishen.CoCaishen.Co
Primary Data for China's Secondary Investment and Stock Markets
  • Login
  • About
  • FAQ
  • Login
  • About
  • FAQ
  • Twitter
  • LInkedIn

Company: Tasly Pharmaceutica Group

Zhongsheng Ruichuang's 3CL protease inhibitor clinical trial application was accepted by NMPA, and domestic new crown drugs accelerated

  • Post date May 16, 2022 — 08:44 Post Lock Login to View

Read More

Watching the market: Hongtao shares and other 6 stocks stopped in seconds CFi.CN Zhongcai Network

  • Post date May 12, 2022 — 10:35 Post Lock Login to View

Read More

Kaiyuan Securities: Continue to be optimistic about investment opportunities in the new crown testing, consumer medical and new crown drug industry chains

  • Post date May 10, 2022 — 10:07 Post Lock Login to View

Read More

Tasly: As of the first quarter, the company's drug sales revenue in the field of liver disease treatment increased by 33%, and related drugs are currently mainly sold in China Teller Report Teller Report

  • Post date May 9, 2022 — 02:41 Post Lock Login to View

Read More

Tasly: The company's main products are mainly exclusive drugs.

  • Post date May 9, 2022 — 00:41 Post Lock Login to View

Read More

Tasly: As of the first quarter, the company's drug sales revenue in the field of liver disease treatment increased by 33%, and related drugs are currently mainly sold in China.

  • Post date May 9, 2022 — 00:41 Post Lock Login to View

Read More

Tasly: The company's liver disease drug Shuilinjia is indicated for the recovery of abnormal liver function in patients with acute and chronic hepatitis and fatty liver.

  • Post date May 8, 2022 — 20:38 Post Lock Login to View

Read More

Over 20 domestic pharmaceutical companies deploy PARP inhibitors to target ovarian cancer, the "king of women's cancer"

  • Post date May 8, 2022 — 14:40 Post Lock Login to View

Read More

Attacking the "King of Women's Cancer" ovarian cancer, more than 20 domestic pharmaceutical companies deploy PARP inhibitors_Shenzhen Hotline

  • Post date May 8, 2022 — 13:25 Post Lock Login to View

Read More

More than 50 local companies have deployed another innovative antibody-conjugated drug to "go overseas"

  • Post date May 6, 2022 — 21:48 Post Lock Login to View

Read More

Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline_Shenzhen Hotline

  • Post date May 6, 2022 — 00:07 Post Lock Login to View

Read More

Shanghai's "acceleration" of resumption of work and production: Chinese and foreign pharmaceutical and medical enterprises are making every effort to "recover"丨Frontline-News Channel-Hexun.com

  • Post date May 5, 2022 — 21:37 Post Lock Login to View

Read More

Life is full of love and youth blooms pay tribute to young people who go to love Finance and Economics

  • Post date May 4, 2022 — 09:16 Post Lock Login to View

Read More

Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball

  • Post date May 3, 2022 — 18:04 Post Lock Login to View

Read More

375 A-share biopharmaceutical companies released their first quarterly reports, and 40% of the companies' net profit declined

  • Post date May 2, 2022 — 22:09 Post Lock Login to View

Read More

What are the exclusive Chinese medicine concept stocks in 2022? Exclusive list and ranking of leading Chinese medicine stocks (stock code)

  • Post date May 2, 2022 — 11:17 Post Lock Login to View

Read More

"Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network

  • Post date May 2, 2022 — 03:39 Post Lock Login to View

Read More

"Viagra concept stock" Laimei Pharmaceutical lost about 100 million in advance, and disputes continued to finance channel Rongyi Information Network

  • Post date May 2, 2022 — 01:59 Post Lock Login to View

Read More

Beijing Capital Securities maintains Tasly's buy rating Xinhua

  • Post date April 29, 2022 — 21:39 Post Lock Login to View

Read More

On April 28, institutional seats sold net and bought 26 shares CFi.CN Zhongcai Network

  • Post date April 29, 2022 — 11:40 Post Lock Login to View

Read More

Want to see more data? Registered subscribers can see all the data.

   Register Now!
  • Twitter
  • LInkedIn
  • About Us
  • Contact Us
  • FAQ
  • Privacy Policy
  • Terms and Conditions
  • Corporate Subscription

Copyright © 2025 Caishen.Co. All rights reserved.

To the top ↑ Up ↑
China Money NetworkA service of China Money Network Ltd.